PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wheaton Precious Metals Corp. (WPM)
96.701.20 (1.26%)
95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.89%
Positive revenue growth while FSM is negative. John Neff might see a notable competitive edge here.
-3.63%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-4.14%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-4.14%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-3.92%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-4.76%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-2.44%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.06%
Share reduction more than 1.5x FSM's 0.75%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.12%
Reduced diluted shares while FSM is at 0.16%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
5.56%
OCF growth under 50% of FSM's 336.22%. Michael Burry might suspect questionable revenue recognition or rising costs.
5.81%
FCF growth under 50% of FSM's 349.02%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
513.84%
10Y CAGR of 513.84% while FSM is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
204.35%
5Y revenue/share CAGR 1.25-1.5x FSM's 163.50%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
309.78%
3Y revenue/share CAGR above 1.5x FSM's 123.05%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
4244.28%
10Y OCF/share CAGR under 50% of FSM's 9724.02%. Michael Burry would worry about a persistent underperformance in cash creation.
289.09%
5Y OCF/share CAGR at 50-75% of FSM's 567.43%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
450.63%
3Y OCF/share CAGR above 1.5x FSM's 187.12%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
13671.58%
Net income/share CAGR above 1.5x FSM's 309.71% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
287.69%
5Y net income/share CAGR above 1.5x FSM's 143.80%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
546.07%
3Y net income/share CAGR above 1.5x FSM's 138.95%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
2996.55%
10Y equity/share CAGR above 1.5x FSM's 843.53%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
139.38%
5Y equity/share CAGR above 1.5x FSM's 71.38%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
83.50%
3Y equity/share CAGR similar to FSM's 77.89%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.66%
Firm’s AR is declining while FSM shows 2.84%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
1.70%
Asset growth at 50-75% of FSM's 2.80%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
2.90%
BV/share growth above 1.5x FSM's 0.70%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-9.99%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-1.99%
We cut SG&A while FSM invests at 9.01%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.